Literature DB >> 22962672

A piece of the puzzle: what does BRAF status mean in the management of patients with papillary thyroid carcinoma?

David H Sarne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22962672     DOI： 10.1210/jc.2012-2760

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

Review 1.  Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Authors:  Markus Luster; Theresia Weber; Frederik A Verburg
Journal:  Nat Rev Endocrinol       Date:  2014-07-01       Impact factor: 43.330

2.  Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.

Authors:  Mingzhao Xing; Ali S Alzahrani; Kathryn A Carson; Young Kee Shong; Tae Yong Kim; David Viola; Rossella Elisei; Bela Bendlová; Linwah Yip; Caterina Mian; Federica Vianello; R Michael Tuttle; Eyal Robenshtok; James A Fagin; Efisio Puxeddu; Laura Fugazzola; Agnieszka Czarniecka; Barbara Jarzab; Christine J O'Neill; Mark S Sywak; Alfred K Lam; Garcilaso Riesco-Eizaguirre; Pilar Santisteban; Hirotaka Nakayama; Roderick Clifton-Bligh; Giovanni Tallini; Elizabeth H Holt; Vlasta Sýkorová
Journal:  J Clin Oncol       Date:  2014-10-20       Impact factor: 44.544

3.  Morphology predicts BRAF (V⁶⁰⁰E) mutation in papillary thyroid carcinoma: an interobserver reproducibility study.

Authors:  Renu K Virk; Constantine G A Theoharis; Avinash Prasad; David Chhieng; Manju L Prasad
Journal:  Virchows Arch       Date:  2014-02-19       Impact factor: 4.064

4.  Immunohistochemical detection of mutated BRAF V600E supports the clonal origin of BRAF-induced thyroid cancers along the spectrum of disease progression.

Authors:  Ronald A Ghossein; Nora Katabi; James A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2013-06-17       Impact factor: 5.958

5.  BRAF V600E mutation and papillary thyroid cancer--in reply.

Authors:  Mingzhao Xing
Journal:  JAMA       Date:  2013-08-07       Impact factor: 56.272

6.  Precise Detection of Gene Mutations in Fine-Needle Aspiration Specimens of the Papillary Thyroid Microcarcinoma Using Next-Generation Sequencing.

Authors:  Feng-Xia Yu; Min-Xia Hu; Han-Xue Zhao; Li-Juan Niu; Xue-Yu Rong; Wei-Hua Li; Qiang Zhu; Jian-Ming Ying; Ning Lyu
Journal:  Int J Endocrinol       Date:  2019-02-19       Impact factor: 3.257

7.  Molecular Predictors for Advanced Papillary Thyroid Carcinoma Recurrence.

Authors:  Taciana Padilha de Castro; Ricardo Cortez Cardoso Penha; Luisa Aguirre Buexm; Flávia Nascimento de Carvalho; Raquel de Vasconcellos Carvalhaes Oliveira; Fernando Vaz Agarez; Luciana Wernersbach Pinto; Denise P Carvalho
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-05       Impact factor: 5.555
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.